Traders work on the floor of the New York Stock Exchange.

Check out the companies making headlines after the bell Thursday:

Biotech company Amgen beat estimates by 14 cents with adjusted second-quarter earnings of $2.57 a share, while revenue came in at $5.37 billion, topping estimates of $5.32 billion. Shares rose about 2 percent after the announcement.